Färkkilä M - Search Results

1

Recombinant interferon gamma treatment in non-small cell lung cancer. Antitumour effect and cardiotoxicity.

Mattson K, Niiranen A, Pyrhönen S, Färkkilä M, Cantell K. Mattson K, et al. Among authors: farkkila m. Acta Oncol. 1991;30(5):607-10. doi: 10.3109/02841869109092427. Acta Oncol. 1991. PMID: 1654065

2

Effect of interferon-gamma on biogenic amine metabolism, electroencephalographic recordings, and transient potentials.

Färkkilä M, Iivanainen M, Härkönen M, Laakso J, Mattson K, Niiranen A, Larsen TA, Cantell K. Färkkilä M, et al. Clin Neuropharmacol. 1988 Feb;11(1):63-7. doi: 10.1097/00002826-198802000-00006. Clin Neuropharmacol. 1988. PMID: 2832059

3

Dementia-like, largely reversible syndrome after cranial irradiation and prolonged interferon treatment.

Laaksonen R, Niiranen A, Iivanainen M, Mattson K, Holsti L, Färkkilä M, Cantell K. Laaksonen R, et al. Among authors: farkkila m. Ann Clin Res. 1988;20(3):201-3. Ann Clin Res. 1988. PMID: 2848440

4

Behavioral assessment of patients treated with alpha-interferon.

Niiranen A, Laaksonen R, Iivanainen M, Mattson K, Färkkilä M, Cantell K. Niiranen A, et al. Among authors: farkkila m. Acta Psychiatr Scand. 1988 Nov;78(5):622-6. doi: 10.1111/j.1600-0447.1988.tb06395.x. Acta Psychiatr Scand. 1988. PMID: 3232542

5

Memory and psychomotor impairment following high-dose interferon treatment in amyotrophic lateral sclerosis.

Iivanainen M, Laaksonen R, Niemi ML, Färkkilä M, Bergström L, Mattson K, Niiranen A, Cantell K. Iivanainen M, et al. Among authors: farkkila m. Acta Neurol Scand. 1985 Nov;72(5):475-80. doi: 10.1111/j.1600-0404.1985.tb00904.x. Acta Neurol Scand. 1985. PMID: 4082913

6

Neurotoxicity of interferon.

Mattson K, Niiranen A, Iivanainen M, Färkkilä M, Bergström L, Holsti LR, Kauppinen HL, Cantell K. Mattson K, et al. Among authors: farkkila m. Cancer Treat Rep. 1983 Oct;67(10):958-61. Cancer Treat Rep. 1983. PMID: 6194882 No abstract available.

7

Neurotoxic and other side effects of high-dose interferon in amyotrophic lateral sclerosis.

Färkkilä M, Iivanainen M, Roine R, Bergström L, Laaksonen R, Niemi ML, Cantell K. Färkkilä M, et al. Acta Neurol Scand. 1984 Jul;70(1):42-6. doi: 10.1111/j.1600-0404.1984.tb00801.x. Acta Neurol Scand. 1984. PMID: 6206681

8

Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma.

Färkkilä M, Jääskeläinen J, Kallio M, Blomstedt G, Raininko R, Virkkunen P, Paetau A, Sarelin H, Mäntylä M. Färkkilä M, et al. Br J Cancer. 1994 Jul;70(1):138-41. doi: 10.1038/bjc.1994.263. Br J Cancer. 1994. PMID: 8018525 Free PMC article. Clinical Trial.

9

Disturbance of the water and electrolyte balance during high-dose interferon treatment.

Färkkilä AM, Iivanainen MV, Färkkilä MA. Färkkilä AM, et al. Among authors: farkkila ma. J Interferon Res. 1990 Apr;10(2):221-7. doi: 10.1089/jir.1990.10.221. J Interferon Res. 1990. PMID: 2341751 Clinical Trial.

10

Reversible cognitive decline during high-dose alpha-interferon treatment.

Poutiainen E, Hokkanen L, Niemi ML, Färkkilä M. Poutiainen E, et al. Among authors: farkkila m. Pharmacol Biochem Behav. 1994 Apr;47(4):901-5. doi: 10.1016/0091-3057(94)90294-1. Pharmacol Biochem Behav. 1994. PMID: 8029260 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

584 results

Search Page

Filters